Variant report
Variant | rs12139630 |
---|---|
Chromosome Location | chr1:46350935-46350936 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:46280079..46281713-chr1:46349138..46351196,2 | K562 | blood: | |
2 | chr1:46152030..46155728-chr1:46349059..46353962,4 | K562 | blood: | |
3 | chr1:46349975..46352089-chr1:46365133..46367847,2 | K562 | blood: | |
4 | chr1:46345992..46348458-chr1:46350883..46353705,2 | K562 | blood: | |
5 | chr1:45972293..45974739-chr1:46350771..46352345,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000159596 | Chromatin interaction |
ENSG00000159592 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10749860 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs10789474 | 0.90[CHB][hapmap];0.87[JPT][hapmap] |
rs10789475 | 0.90[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs10789478 | 0.82[CHB][hapmap] |
rs10789481 | 0.96[CEU][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes];0.83[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10789487 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1085243 | 1.00[CEU][hapmap];0.82[YRI][hapmap] |
rs10890347 | 0.95[CHB][hapmap];0.90[JPT][hapmap] |
rs10890352 | 0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs10890354 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs10890355 | 0.82[YRI][hapmap] |
rs10890361 | 0.95[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs10890363 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10890365 | 0.81[CHB][hapmap] |
rs10890367 | 0.86[AFR][1000 genomes];0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10890369 | 0.84[AFR][1000 genomes];0.83[AMR][1000 genomes];0.84[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs10890371 | 0.83[YRI][hapmap] |
rs10890372 | 0.80[YRI][hapmap] |
rs11211188 | 0.87[AMR][1000 genomes];0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs11211189 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.86[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs11211197 | 0.92[AMR][1000 genomes];0.84[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs11211198 | 0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs11211199 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs11211200 | 0.81[CHB][hapmap] |
rs11211203 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs11211204 | 0.81[CHB][hapmap] |
rs11211208 | 1.00[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211213 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11211217 | 0.82[CHB][hapmap];0.80[YRI][hapmap] |
rs11211224 | 0.90[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs11211228 | 0.80[YRI][hapmap] |
rs11211230 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11211234 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11211235 | 0.80[YRI][hapmap] |
rs11211236 | 0.80[YRI][hapmap] |
rs11211237 | 0.81[YRI][hapmap] |
rs11211241 | 0.85[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11211243 | 0.80[YRI][hapmap] |
rs11211251 | 0.81[AMR][1000 genomes] |
rs11576305 | 0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11579634 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.89[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11589562 | 0.95[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];0.96[YRI][hapmap];0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11810993 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12021587 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12027345 | 0.86[AMR][1000 genomes] |
rs12032115 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12045165 | 0.86[AMR][1000 genomes];0.82[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs12049588 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12076580 | 0.81[CHB][hapmap] |
rs12132540 | 1.00[CEU][hapmap];0.85[YRI][hapmap] |
rs12143096 | 0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12144263 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12405451 | 0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12409773 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12410070 | 0.95[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12410071 | 0.92[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12411269 | 0.83[AFR][1000 genomes];0.92[AMR][1000 genomes];0.84[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs12561806 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs12564541 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs12565042 | 0.96[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs12739439 | 0.84[AFR][1000 genomes];0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12740503 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12757810 | 0.83[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12760175 | 0.91[EUR][1000 genomes] |
rs1707321 | 1.00[CEU][hapmap];0.82[YRI][hapmap] |
rs1707333 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs1707336 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap] |
rs1707340 | 1.00[CEU][hapmap] |
rs1768809 | 0.90[JPT][hapmap];0.82[YRI][hapmap] |
rs1768816 | 1.00[CEU][hapmap];0.81[YRI][hapmap] |
rs2275426 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs28647556 | 0.80[YRI][hapmap] |
rs3013595 | 0.83[CEU][hapmap] |
rs34102169 | 0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs34175029 | 0.82[AFR][1000 genomes];0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs34325724 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs35154628 | 0.86[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs35743647 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs35945607 | 0.84[EUR][1000 genomes] |
rs4073846 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4076006 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.84[AFR][1000 genomes];0.89[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4134386 | 0.94[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4233500 | 0.83[AFR][1000 genomes];0.89[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4274104 | 0.83[CEU][hapmap];0.81[YRI][hapmap] |
rs4298677 | 0.81[CHB][hapmap] |
rs4376778 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs4390216 | 0.81[CHB][hapmap] |
rs4440807 | 0.83[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4457512 | 0.83[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4504835 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4539075 | 0.82[CHB][hapmap];0.80[YRI][hapmap] |
rs4545281 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.85[YRI][hapmap];0.87[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4579700 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4626927 | 0.91[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.88[YRI][hapmap] |
rs4630155 | 0.82[CHB][hapmap] |
rs4638056 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4660317 | 0.91[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4660318 | 0.81[CHB][hapmap] |
rs4660319 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs4660321 | 1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4660322 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[YRI][hapmap];0.97[AFR][1000 genomes];0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4660328 | 0.80[YRI][hapmap] |
rs4660885 | 0.95[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.81[AMR][1000 genomes];0.81[ASN][1000 genomes] |
rs4660889 | 0.82[CHB][hapmap];0.80[YRI][hapmap] |
rs4660895 | 0.81[CHB][hapmap];0.82[YRI][hapmap] |
rs4660898 | 0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4660900 | 0.80[YRI][hapmap] |
rs4660910 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs61102033 | 0.90[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs61783200 | 0.84[AFR][1000 genomes];0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs61783217 | 0.88[AFR][1000 genomes];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs61783220 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6429576 | 0.83[CEU][hapmap] |
rs6429580 | 0.81[CHB][hapmap] |
rs6429582 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6656022 | 0.90[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6656992 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6657720 | 0.80[YRI][hapmap] |
rs6660835 | 0.89[AFR][1000 genomes];0.89[AMR][1000 genomes];0.95[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs6661163 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.82[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6661593 | 0.86[AFR][1000 genomes];0.85[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6661910 | 0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6662548 | 0.88[AFR][1000 genomes];0.94[AMR][1000 genomes];0.91[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6666743 | 1.00[CEU][hapmap];0.86[CHB][hapmap];0.92[YRI][hapmap];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs6668284 | 0.86[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs6669522 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6672115 | 0.81[CHB][hapmap] |
rs6672898 | 0.89[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6675222 | 0.82[CHB][hapmap];0.80[YRI][hapmap] |
rs6675259 | 0.85[CHB][hapmap] |
rs6675946 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs6677007 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6680211 | 0.96[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs6680380 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6680428 | 0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs6681068 | 0.83[YRI][hapmap] |
rs6682683 | 0.81[CHB][hapmap] |
rs6683274 | 0.95[CHB][hapmap];0.85[JPT][hapmap] |
rs6683500 | 0.88[AMR][1000 genomes] |
rs6686134 | 1.00[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs6687301 | 0.80[YRI][hapmap] |
rs6688365 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6694340 | 1.00[CEU][hapmap];0.86[CHB][hapmap];0.92[YRI][hapmap];0.94[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs6695809 | 0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6697557 | 0.84[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6697843 | 0.92[AFR][1000 genomes];0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6698247 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs6700597 | 0.95[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6701614 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6703960 | 0.81[AMR][1000 genomes] |
rs7512395 | 0.82[CHB][hapmap] |
rs7515491 | 0.84[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs7520050 | 0.93[YRI][hapmap] |
rs7522601 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs7524495 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.86[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs7526369 | 0.80[YRI][hapmap] |
rs7526532 | 0.96[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs7526678 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7527244 | 0.82[CHB][hapmap] |
rs7531911 | 0.81[CHB][hapmap] |
rs7533956 | 0.83[AFR][1000 genomes];0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs7539932 | 0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs7540325 | 0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7540578 | 0.95[CHB][hapmap];0.90[JPT][hapmap] |
rs7540699 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7546237 | 0.81[CHB][hapmap];0.81[YRI][hapmap] |
rs7547189 | 0.82[CHB][hapmap];0.80[YRI][hapmap] |
rs7547284 | 0.80[YRI][hapmap] |
rs7550746 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7556436 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7556615 | 0.81[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs785464 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs785472 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs785473 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs785479 | 1.00[YRI][hapmap];0.82[AFR][1000 genomes];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs785511 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs809775 | 1.00[CEU][hapmap];0.83[YRI][hapmap] |
rs9429088 | 0.95[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];0.83[YRI][hapmap] |
rs9429183 | 1.00[CEU][hapmap] |
rs946527 | 0.82[YRI][hapmap] |
rs946528 | 0.84[CHB][hapmap];0.81[YRI][hapmap] |
rs946529 | 1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.86[AMR][1000 genomes];0.84[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs9787208 | 0.96[AMR][1000 genomes];0.93[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv932680 | chr1:45935520-46686477 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
2 | nsv868828 | chr1:45953923-46686477 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
3 | nsv871928 | chr1:46024701-46609736 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 123 gene(s) | inside rSNPs | diseases |
4 | nsv1014128 | chr1:46097670-46394540 | Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 77 gene(s) | inside rSNPs | diseases |
5 | nsv1006861 | chr1:46144479-46417621 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 76 gene(s) | inside rSNPs | diseases |
6 | nsv1003049 | chr1:46144479-46476149 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 78 gene(s) | inside rSNPs | diseases |
7 | nsv1008219 | chr1:46160098-46493958 | Genic enhancers Strong transcription ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
8 | nsv534943 | chr1:46160098-46493958 | Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
9 | nsv1000498 | chr1:46171836-46438252 | Weak transcription ZNF genes & repeats Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
10 | nsv870791 | chr1:46182916-46398415 | Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
11 | nsv998925 | chr1:46184925-46353041 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
12 | nsv1003986 | chr1:46184925-46417621 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
13 | nsv1007501 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
14 | nsv534944 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
15 | nsv1006891 | chr1:46189258-46408032 | Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
16 | nsv1009355 | chr1:46189258-46463012 | Active TSS Genic enhancers ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
17 | nsv871312 | chr1:46196813-46353332 | Enhancers Active TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
18 | nsv546158 | chr1:46216575-46495434 | Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
19 | nsv870911 | chr1:46216575-46498375 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
20 | nsv1013628 | chr1:46221617-46356565 | Enhancers Flanking Active TSS Strong transcription Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 12 gene(s) | inside rSNPs | diseases |
21 | nsv431268 | chr1:46223080-46495480 | Strong transcription Enhancers Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
22 | nsv546159 | chr1:46223086-46398415 | Enhancers Strong transcription Genic enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
23 | nsv461417 | chr1:46223086-46416348 | Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
24 | nsv546160 | chr1:46223086-46416348 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
25 | nsv524147 | chr1:46236098-46438076 | Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
26 | nsv1007162 | chr1:46244432-46417621 | Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
27 | nsv1015136 | chr1:46244432-46439533 | Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
28 | nsv1003517 | chr1:46244432-46609881 | Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
29 | nsv1007759 | chr1:46248667-46493959 | Enhancers Weak transcription Strong transcription Active TSS Genic enhancers ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
30 | nsv534945 | chr1:46248667-46493959 | Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
31 | nsv916232 | chr1:46248686-46493918 | Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
32 | nsv437479 | chr1:46272879-46411146 | Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
33 | nsv1013729 | chr1:46286329-46363880 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | inside rSNPs | diseases |
34 | nsv1009527 | chr1:46286329-46520127 | Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
35 | nsv546161 | chr1:46311275-46498375 | Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
36 | nsv1009474 | chr1:46320433-46557734 | Weak transcription Flanking Active TSS Enhancers Strong transcription Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
37 | nsv1003554 | chr1:46331254-46410657 | Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
38 | nsv1005189 | chr1:46335186-46949309 | Bivalent/Poised TSS Weak transcription Active TSS Bivalent Enhancer Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 72 gene(s) | inside rSNPs | diseases |
39 | nsv534946 | chr1:46335186-46949309 | ZNF genes & repeats Strong transcription Flanking Active TSS Weak transcription Enhancers Genic enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 72 gene(s) | inside rSNPs | diseases |
40 | esv2761743 | chr1:46339858-47026743 | Active TSS Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 80 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs12139630 | CCDC163P | cis | Artery Aorta | GTEx |
rs12139630 | CCDC163P | cis | Thyroid | GTEx |
rs12139630 | Hs.396207 | cis | multi-tissue | Pritchard |
rs12139630 | CCDC163P | cis | Muscle Skeletal | GTEx |
rs12139630 | CCDC163P | cis | Esophagus Muscularis | GTEx |
rs12139630 | LOC126661 | Cis_1M | lymphoblastoid | RTeQTL |
rs12139630 | CCDC163P | cis | Whole Blood | GTEx |
rs12139630 | MAST2 | cis | Artery Aorta | GTEx |
rs12139630 | GPBP1L1 | cis | Lymphoblastoid | GTEx |
rs12139630 | CCDC163P | cis | Stomach | GTEx |
rs12139630 | CCDC163P | cis | Artery Tibial | GTEx |
rs12139630 | CCDC163P | cis | Heart Left Ventricle | GTEx |
rs12139630 | MAST2 | cis | Artery Tibial | GTEx |
rs12139630 | IPP | Cis_1M | lymphoblastoid | RTeQTL |
rs12139630 | CCDC163P | cis | Skin Sun Exposed Lower leg | GTEx |
rs12139630 | CCDC163P | cis | Esophagus Mucosa | GTEx |
rs12139630 | CCDC163P | cis | lung | GTEx |
rs12139630 | CCDC163P | cis | Nerve Tibial | GTEx |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:46330200-46353200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:46330200-46357600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr1:46332200-46357400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr1:46333800-46357400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr1:46336600-46356800 | Weak transcription | Small Intestine | intestine |
6 | chr1:46336600-46357600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr1:46337800-46356000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
8 | chr1:46338000-46357400 | Weak transcription | Hela-S3 | cervix |
9 | chr1:46338400-46353000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr1:46338400-46357600 | Weak transcription | Fetal Intestine Large | intestine |
11 | chr1:46339200-46355000 | Weak transcription | Fetal Intestine Small | intestine |
12 | chr1:46342200-46357000 | Weak transcription | HUVEC | blood vessel |
13 | chr1:46342200-46391200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
14 | chr1:46343200-46352400 | Weak transcription | Psoas Muscle | Psoas |
15 | chr1:46346400-46357000 | Weak transcription | Left Ventricle | heart |
16 | chr1:46347200-46357400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
17 | chr1:46347400-46353000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr1:46347400-46357200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr1:46347400-46357400 | Weak transcription | NH-A | brain |
20 | chr1:46347400-46357400 | Weak transcription | NHDF-Ad | bronchial |
21 | chr1:46347400-46378400 | Weak transcription | Brain Germinal Matrix | brain |
22 | chr1:46348400-46352400 | Weak transcription | Fetal Muscle Leg | muscle |
23 | chr1:46348600-46351000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
24 | chr1:46348600-46352800 | Weak transcription | HSMMtube | muscle |
25 | chr1:46349200-46351000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr1:46349600-46369000 | Weak transcription | Dnd41 | blood |
27 | chr1:46349800-46351000 | Enhancers | A549 | lung |
28 | chr1:46349800-46351200 | Enhancers | HepG2 | liver |
29 | chr1:46349800-46352800 | Weak transcription | Osteobl | bone |
30 | chr1:46349800-46353200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
31 | chr1:46349800-46353800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
32 | chr1:46349800-46357600 | Weak transcription | Rectal Smooth Muscle | rectum |
33 | chr1:46350000-46357400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
34 | chr1:46350400-46351000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
35 | chr1:46350400-46351200 | Strong transcription | HSMM | muscle |
36 | chr1:46350400-46351400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
37 | chr1:46350600-46351000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
38 | chr1:46350600-46351400 | Weak transcription | Duodenum Mucosa | Duodenum |
39 | chr1:46350600-46351400 | Weak transcription | Fetal Lung | lung |
40 | chr1:46350600-46354600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
41 | chr1:46350600-46357600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
42 | chr1:46350800-46352400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
43 | chr1:46350800-46378800 | Weak transcription | K562 | blood |